Zhejiang Kanying Import & Export Co. Ltd 86--17169758851 kanyingexport@gmail.com
99% Pure Finasteride Powder Cas 98319-26-7 Active Pharmaceutical Ingredient API

99% Pure Finasteride Powder Cas 98319-26-7 Active Pharmaceutical Ingredient API

  • High Light

    99% Pure Finasteride Powder

    ,

    cas 98319-26-7 Finasteride Powder

    ,

    98319-26-7 Active Pharmaceutical Ingredient API

  • Brand Name
    Kan Ying
  • Product Name
    Finasteride
  • Place Of Origin
    India
  • Shelf Life
    2 Years
  • Purity
    99%
  • Color
    White Or Quasi-white Powder.
  • Storage
    Cool Dry Place
  • CAS No
    98319-26-7
  • Place of Origin
    India
  • Brand Name
    Kan Ying
  • Minimum Order Quantity
    1kg
  • Price
    To discuss
  • Packaging Details
    1kg-25kg
  • Delivery Time
    2
  • Payment Terms
    L/C, D/A, D/P, T/T, Western Union, MoneyGram,Dollars
  • Supply Ability
    200000

99% Pure Finasteride Powder Cas 98319-26-7 Active Pharmaceutical Ingredient API

finasteride Prostatic hyperplasia Active Pharmaceutical Ingredient API

 

1. Product title: Finasteride

 

2. Product Description : Finasteride is a 4-azasteroid compound that is a specific inhibitor of the intracellular enzyme type II 5a reductase involved in the metabolism of testosterone to the more potent dihydrotestosterone. And benign prostatic hyperplasia, or prostatic hypertrophy, depends on the conversion of testosterone to dihydrotestosterone in the prostate. This drug is very effective in reducing the amount of DHT in the blood and prostate. Finasteride has no affinity for androgen receptors. Finastandrogen is a 5α reductase inhibitor, which can reduce the size of the prostate, improve symptoms, increase urinary flow rate and prevent the progression of benign prostatic hyperplasia (BPH) by inhibiting the conversion of testosterone to dihydrotestosterone (DHT) through its hormonal mechanism.

 

3. Product parameter table:

Product Name

finasteride

Specification 99%
Appearance White or light white power Main Effect Prostatic hyperplasia
Brand Name Kan Ying Store-method Cool Dry Place
Shelf Life 2 Years When
Properly Stored
From India

4. Utility function:

Finasteride is a 4-azasteroid compound that is a specific inhibitor of the intracellular enzyme type II 5a reductase involved in the metabolism of testosterone to the more potent dihydrotestosterone. And benign prostatic hyperplasia, or prostatic hypertrophy, depends on the conversion of testosterone to dihydrotestosterone in the prostate. This drug is very effective in reducing the amount of DHT in the blood and prostate. Finasteride has no affinity for androgen receptors.

 

This medication in a long-term efficacy and safety of (PLESS), in the study of symptoms of moderate to severe hyperplasia of prostate, 3016 prostate hyperplasia patients treated with this drug is 4 years relevant disposal (surgical intervention), urinary system such as transurethral resection of the prostate gland and other resection of the prostate, or need to insert the catheter acute urinary retention is evaluated. In this double-blind, randomized, placebo-controlled, multicenter study, treatment with this drug resulted in a 51% reduction in the overall risk of urinary tract disposal, accompanied by significant and sustained prostate volume reduction, as well as a sustained increase in maximum urinary flow rate and improvement in symptoms.

 

5. Pharmacological effects:

Pharmacological effects: Finasteride is a compound of 4-azosteroid hormone, a specific Ⅱ type 5α-reductase inhibitor, which inhibits the conversion of peripheral testosterone to dihydrotestosterone, and reduces the level of dihydrotestosterone in blood, prostate, skin and other tissues. The growth and development of prostate and benign hyperplasia depend on DHT. Finasteride inhibits BPH and improves the related clinical symptoms of BPH by reducing the DHT level in blood and prostate tissue.

 

6. Matters needing attention:

Caution: It is contraindicated for women, children and people allergic to this product. Patients with large amounts of residual urine and/or severe reduced urinary flow should be closely monitored for urinary tract obstruction.

 

7. Pictures of the product:

 

99% Pure Finasteride Powder Cas 98319-26-7 Active Pharmaceutical Ingredient API 099% Pure Finasteride Powder Cas 98319-26-7 Active Pharmaceutical Ingredient API 1